Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Philips grows clinical informatics portfolio with Israeli buy

This article was originally published in Clinica

Executive Summary

Philips is to boost its range of picture archiving and communication systems (PACS) by acquiring Israeli firm CDP Medical. Philips is to purchase the firm from its parent company, medical device distributor Medtechnica, for an undisclosed fee. The deal will see Petah Tikva-based CDP become part of Philips Healthcare’s patient care and clinical informatics business. CDP was founded in 2000 and has technology installed in 300 hospitals globally, with growth coming particularly in the Latin America region last year. Philips said the deal was complementary to its own iSite PACS technology. Earlier this year, Philips strengthened its clinical informatics business by purchasing Brazilian healthcare information system provider Tecso Informatica. The CDP acquisition comes less than a week after Philips delved into the M&A market to secure the services of Shanghai Apex Electronics Technology, a Chinese manufacturer of ultrasound transducers (, 28 July 2010).

You may also be interested in...

Alere aided by professional diagnostics sales in fourth quarter

Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.

Integra and Stout to work on expandable interbody device

Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.

Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials

Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts